These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Phase transformations of erythromycin A dihydrate during pelletisation and drying. Römer M, Heinämäki J, Miroshnyk I, Sandler N, Rantanen J, Yliruusi J. Eur J Pharm Biopharm; 2007 Aug; 67(1):246-52. PubMed ID: 17270405 [Abstract] [Full Text] [Related]
3. Phase transformation of erythromycin A dihydrate during fluid bed drying. Römer M, Heinämäki J, Miroshnyk I, Kivikero N, Sandler N, Rantanen J, Yliruusi J. J Pharm Sci; 2008 Sep; 97(9):4020-9. PubMed ID: 18200525 [Abstract] [Full Text] [Related]
4. Influence of solvents on the variety of crystalline forms of erythromycin. Mirza S, Miroshnyk I, Heinämäki J, Christiansen L, Karjalainen M, Yliruusi J. AAPS PharmSci; 2003 Sep; 5(2):E12. PubMed ID: 12866939 [Abstract] [Full Text] [Related]
5. Physico-chemical characterization of interactions between erythromycin and various film polymers. Sarisuta N, Kumpugdee M, Müller BW, Puttipipatkhachorn S. Int J Pharm; 1999 Sep 20; 186(2):109-18. PubMed ID: 10486428 [Abstract] [Full Text] [Related]
11. Role of an isomorphic desolvate in dissolution failures of an erythromycin tablet formulation. Bauer JF, Dziki W, Quick JE. J Pharm Sci; 1999 Nov 24; 88(11):1222-7. PubMed ID: 10564073 [Abstract] [Full Text] [Related]
13. Study and characterization of crystalline hydrate/polymorph forms of 5,11-dihydro-11-ethyl-5-methyl-8-(2-(1-oxido-4-quinolinyl)ethyl-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepin-6-one by solid-state NMR and solution NMR. Gonnella NC, Smoliga JA, Campbell S, Busacca CA, Cerreta M, Varsolona R, Norwood DL. J Pharm Biomed Anal; 2010 Apr 06; 51(5):1047-53. PubMed ID: 20018474 [Abstract] [Full Text] [Related]